ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SPI Spire Healthcare Group Plc

252.00
1.50 (0.60%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Spire Healthcare Group Plc LSE:SPI London Ordinary Share GB00BNLPYF73 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.50 0.60% 252.00 251.00 252.00 254.00 250.50 250.50 670,361 16:35:07
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Health & Allied Services,nec 1.36B 27.3M 0.0676 37.20 1.02B
Spire Healthcare Group Plc is listed in the Health & Allied Services sector of the London Stock Exchange with ticker SPI. The last closing price for Spire Healthcare was 250.50p. Over the last year, Spire Healthcare shares have traded in a share price range of 204.00p to 254.00p.

Spire Healthcare currently has 404,130,113 shares in issue. The market capitalisation of Spire Healthcare is £1.02 billion. Spire Healthcare has a price to earnings ratio (PE ratio) of 37.20.

Spire Healthcare Share Discussion Threads

Showing 2551 to 2571 of 3300 messages
Chat Pages: Latest  108  107  106  105  104  103  102  101  100  99  98  97  Older
DateSubjectAuthorDiscuss
30/9/2018
09:46
fahads listen to the Q&A, the Berenberg Analyst had no rapport with Justin Ash and was short changed in the response to his question. This grumpiness and ego hit may have led to the Analyst issuing his negative stance. Hence these pseudo experts are vultures or bulls... The Q&A part made be bullish in many ways, debt covenants, BMI struggling and opportunities to regain market share all imo
cantrememberthis2
30/9/2018
09:18
In my opinion, given current (low) utilisation levels, Spire's earnings are significantly below what they potentially could be. Especially keeping in mind that a lot of the costs are fixed, thus any increase in volumes should be significantly positive for margins (the same issue hurts you on the downside when volumes decline as we are seeing right now). Thus in terms of 'true value' - it remains highly subjective and the earnings growth profile will likely determine that.

I have been trying to focus more on the worst case scenario and the downside risk to determine if I should continue to increase my holdings and at what level. Based on my skimming of the annual report...it looks like the liquidation value of the business is around GBP1.2-1.25 (stand to be corrected) - in my mind, that is the worst case scenario. Would anyone concur?

On the positive side, I feel earnings could easily double even on the existing asset base (if volumes start growing), in which case instead of the 20x P/E you see today, that PE could drop to 10x, implying an easy two bagger.

Would like to hear thoughts on this.

fahads
30/9/2018
00:37
It's a US device and so far as I can tell there is no connection.
bountyhunter
29/9/2018
22:35
what is the "spire health tag" being launched by apple, is it a new venture for spire health?
excellance
29/9/2018
20:06
Why mention it then as not really of any relevance when discussing SPI.
bountyhunter
29/9/2018
20:03
Made no comparison to Capita, mentioned someone had referenced CPI here.
Justice, no current position, and don't go short individual stocks.
Posted it now looks a sitting duck for a bid, but there is no guarantee.
I was cautious last year as thought margins and profitability would
come under pressure.

essentialinvestor
29/9/2018
18:28
In here for the long haul. Looking for at least 50% gain from here. Made 36% last year on the last bid. Hospital Corporation of America have been sniffing around Spire for years and were even willing to pay 468p for Mediclinic's stake last year.
justiceforthemany
29/9/2018
17:23
Capita lol! Talk about comparing apples with pairs!! It will be Tesla next!
jfm - the silence in response to your quite reasonable question is palpable!

bountyhunter
29/9/2018
16:43
So you have no position here then EI?
justiceforthemany
29/9/2018
16:25
EI - you're right that the share price history ought to be irrelevant, and I suspect that MDC is in no position to bid. But 'recruitment and retention in the NHS' can be two-sided. Private providers aren't constrained in the same way as the NHS where 'agency staff' play a part in raising wage costs anyway. [I assume I'm right about wages in the private sector ... aren't I?]

Anyway, there might be an investment case at this price, or at some price lower than this. I need to get more up to speed. I wonder how much politics there is here, which could scupper any rational analysis.

Incidentally, I have personal family experience of a local clinic run by Ramsay Health. It's marvellously efficient and happy, and accepts lots of NHS referrals but my strong impression is that staff aren't stretched and there's a significant cushion.

jonwig
29/9/2018
15:23
First observation is this is not just Spire.
If you look at MDC, it's share price has also been hammered.
Outside of a bid, which may happen, the bullish case
rests on reversing the profitability decline.
I no longer work in the industry, however it's widely reported
that recruitment and retaining staff is a major issue atm.
There are thought to be over 100,000 job vacancies in the NHS.
Margins are a key factor in profitabilility, and scarcity
of skilled workers is unhelpful.

In terms of attempting to value a particular company, I don't look
at previous share price levels, it can often be misleading, or just indicate exuberance
at a given point in time.
Someone here mentioned Capita, Capita is a shadow of the company it once
was. Referencing past share prices in cases like CPI is meaningless as a result.

essentialinvestor
29/9/2018
15:09
Also given your previous warning where is the bottom here in your eyes and what do you think is the true value of Spire Healthcare?
justiceforthemany
29/9/2018
14:20
We all know about the lower EPS EI but this could change rapidly due to the largest NHS waiting lists ever recorded. Net debt is down slightly from year end EI and the balance sheet/net assets has also barely changed. What is your position here and are you saying a drop from 400p to 140p for such a defensive sector is justified?
justiceforthemany
29/9/2018
13:04
It's trading a lot lower as profitability is falling and net debt rising.
People appear to focus on the share price level, while ignoring changing fundamentals.

I warned here a couple of times previously, however would now agree they
are a sitting duck, if someone wants to bid. No guarantee of that.

essentialinvestor
29/9/2018
12:41
And if you had told MDC they wouldn't have believed their luck!
bountyhunter
29/9/2018
12:28
Put it this way if I had told you 2 years ago that the largest British private healthcare company by revenue would be trading at a third of the share price now you would not have believed me or thought that was possible.
justiceforthemany
29/9/2018
12:26
I note none of the major directors have bought any shares since early August. Could be in a closed period. CEO and Chairman have decent sized holdings even at this share price.
justiceforthemany
29/9/2018
10:55
Mediclinic could always offer a cash/share mix. Their share price would then be expected to rise based on the synergies alone.
bountyhunter
29/9/2018
10:38
@ justice - that's an interesting link, thanks.

Politically, it's a bit fraught of course. The Tories would probably go along with raised prices, and Labour would scream 'evil', but go along for a while as they realise the NHS hasn't the capacity.

My personal feeling is that this share price is going down because short-term sentiment is awful, and I'm sceptical about a bid. (Has Mediclinic got the firepower?) Can any chartists read a bottom in sight?

jonwig
29/9/2018
10:17
Stock screeners and traders will see this on technically oversold territory.
I for one will be adding sub 140p...
The MMs mopped up a lot of sell side trades (buys off stop losses etc).
Let's see what the Sunday papers say.
Mediclinic are hurting.

cantrememberthis2
28/9/2018
22:00
Listened to webcast: spot on agreed. Analysts thick at times. They already have 3 months visibility to end of year.
cantrememberthis2
Chat Pages: Latest  108  107  106  105  104  103  102  101  100  99  98  97  Older

Your Recent History

Delayed Upgrade Clock